A bill to amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
90pct
105d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Committee on Veterans' Affairs. Hearings held. Hearings printed: S.Hrg. 118-217.
Read twice and referred to the Committee on Veterans' Affairs. (text: CR S1054-1055)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2025 · second_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2025 · second_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]
2025 · first_quarter · Copyright/Patent/Trademark
Patent abuse issues. S. 1041 Affordable Prescriptions for Patients Act of 2023. S. 1097 Interagency Patent Coordination Act. Medication Affordability and Patent Integrity Act S. 1096 Preserve Access to Affordable Generics and Biosimilars Act Patent Eligibility Restoration Act PREVAIL Act S.5573 A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products. S.43 Skinny Labels, Big Savings Act S.1040 Drug Competition Enhancement Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Pharmacy
340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]
2025 · first_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]
| Democratic |
| WA |
| Richard Blumenthal | Democratic | CT |
| Ron Wyden | Democratic | OR |
| Sherrod Brown | Democratic | OH |
| Susan M. Collins | Republican | ME |
| Thomas R. Carper | Democratic | DE |
| Tim Kaine | Democratic | VA |
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $265,983 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2025 · first_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2025 · first_quarter · Pharmacy
340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2025 · first_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]
Client expense: $28,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Pharmacy
340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 148 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Amy Klobuchar (D-MN) S.1339 - Pharmacy Benefit Manager Reform Act To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S.1542, DRUG Act To improve services provided by pharmacy benefit managers. Sponsor: Sen. Marshall, Roger [R-KS] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN]
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Signed onto February 2023 letter of support for the legislation to make VHA facilities smokefree. Monitor. H.R. 3829: Higher Education Marijuana Research Act of 2023. This bill would streamline the process for institutions of higher education to research marijuana. Monitor. H.R. 5601: Marijuana Opportunity Reinvestment and Expungement Act. This bill would decriminalize marijuana and establish regulations. Monitor. H.R. 6028: States Reform Act of 2023. This bill would decriminalize marijuana and establish regulations. Monitor. H.R. 6038: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. H.R.7094: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. H.R.10444: Public Options for Unrestricted Consumer Harm-reduction Act of 2024. This bill would preempt states from regulating the sale, distribution, possession, or use of certain tobacco products. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S.3108: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. S.3671: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. S.5243: "Cannabinoid Safety and Regulation Act." This bill would authorize the FDA to regulate of cannabis and cannabinoid products. Monitor. S.5363: Get Toxic Substances Out of Schools Act of 2024 This bill would authorize grants for toxic substances remediation in schools, including secondhand smoke. Monitor.
Client expense: Not reported · Firm income: Not reported
2024 · fourth_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; HR 9027 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 9029 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025; HR 9367 Preventing Vape Use Act; S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S 4690 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 890 Guidance out of Regulatory Darkness Act; HR 10515, American Relief Act, 2025; HR 10545, American Relief Act, 2025
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · third_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Signed onto February 2023 letter of support for the legislation to make VHA facilities smokefree. Monitor. H.R. 3829: Higher Education Marijuana Research Act of 2023. This bill would streamline the process for institutions of higher education to research marijuana. Monitor. H.R. 6038: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. H.R.7094: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S.3108: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. S.3671: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. S.5243: "Cannabinoid Safety and Regulation Act." This bill would authorize the FDA to regulate of cannabis and cannabinoid products. Monitor.
Client expense: Not reported · Firm income: Not reported
2024 · third_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; HR 9027 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 9029 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025; HR 9367 Preventing Vape Use Act; S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S 4690 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 890 Guidance out of Regulatory Darkness Act; HR 9747 Continuing Appropriations and Extensions Act, 2025; HR 9494 Continuing Appropriations and Other Matters Act 2025
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · second_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025;
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · second_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.979: This resolution would prioritize tobacco control focus on harm reduction products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Signed onto February 2023 letter of support for the legislation to make VHA facilities smokefree. Monitor. H.R. 3829: Higher Education Marijuana Research Act of 2023. This bill would streamline the process for institutions of higher education to research marijuana. Monitor. H.R. 6038: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. H.R.7094: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S.3108: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. S.3671: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor.
Client expense: Not reported · Firm income: Not reported
2024 · first_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY25 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024; issues related to enforcement of illegal vaping;
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · first_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.979: This resolution would prioritize tobacco control focus on harm reduction products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Signed onto February 2023 letter of support for the legislation to make VHA facilities smokefree. Monitor. H.R. 3829: Higher Education Marijuana Research Act of 2023. This bill would streamline the process for institutions of higher education to research marijuana. Monitor. H.R. 6038: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. H.R.7094: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S.3108: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. S.3671: Marijuana in Federally Assisted Housing Parity Act of 2024. This bill specifies that people who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor.
Client expense: Not reported · Firm income: Not reported
2023 · fourth_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Signed onto February 2023 letter of support for the legislation to make VHA facilities smokefree. Monitor. H.R. 3829: Higher Education Marijuana Research Act of 2023. This bill would streamline the process for institutions of higher education to research marijuana. Monitor. H.R. 6038: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S.3108: PROTECT Act: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill requires a CDC initiative to address the use of electronic cigarettes and emerging tobacco products among youth and young adults. Monitor.
Client expense: Not reported · Firm income: Not reported
2023 · fourth_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; HR 6363 Further Continuing Appropriations and Other Extensions Act, 2024
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2023 · third_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Signed onto February 2023 letter of support for the legislation to make VHA facilities smokefree. Monitor. H.R. 3829: Higher Education Marijuana Research Act of 2023. This bill would streamline the process for institutions of higher education to research marijuana. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor.
Client expense: Not reported · Firm income: Not reported
2023 · third_quarter · Tobacco
Lobbying Report: July 1 - September 30, 2023 (Action Fund) Federal (under tobacco issue code) Legislation: H.R. 4368/S. 2131 - FY 24 Agriculture, Rural Developmental and Food and Drug Administration and Related Agencies Appropriations Bill S. 2624 - FY 24 Labor , Health and Human Services, and Education, and Related Agencies Appropriations Bill H.R. 901 - Disposable ENDS Product Enforcement Act of 2023 H.R. 4775 - Helping Tobacco Users Quit Act END ENDS Act S. 1040 - Smokefree Veterans Health Administration S.2840 - Bipartisan Primary Care and Health Workforce Act H.R. 5378 - Lower Costs, More Transparency Act Preventing Opportunities for Teen E-cigarette and Tobacco Addiction Act Prevention Fund H.R. 5715/S.2929 - Tobacco Tax Equity Act Health Equity and Accountability Act S. 2438/H.R. 4665 - FY 24 Department of State, Foreign Operations, and Related Programs Appropriations Act Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars Prevention and Public Health Fund Nicotine Pouches FDA nicotine standard Tobacco CessationFDA implementation of and enforcement of premarket review Nicotine poisonings from e-cigarettes FDAs strategic plan Congressional Caucus to End the Youth Vaping Epidemic FDA oversight of premium cigars FDA implementation of Tobacco Control Act and hiring authority VA and Tobacco Cancer Moonshot E-cigarette Tax Lung Cancer Screening Labeling Cigarette Filter Waste Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration OMB
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2023 · third_quarter · Tobacco
Lobbying Report: July 1 - September 30, 2023 (Campaign) Federal (under tobacco issue code) Legislation: H.R. 4368/S. 2131- FY 24 Agriculture, Rural Developmental and Food and Drug Administration and Related Agencies Appropriations Bill S. 2624 - FY 24 Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill H.R. 901 - Disposable ENDS Product Enforcement Act of 2023 H.R. 4775 - Helping Tobacco Users Quit Act END ENDS Act S. 1040 - Smokefree Veterans Health Administration S.2840 - Bipartisan Primary Care and Health Workforce Act H.R. 5378 - Lower Costs, More Transparency Act Preventing Opportunities for Teen E-cigarette and Tobacco Addiction Act Prevention Fund H.R. 5715/S.2929 - Tobacco Tax Equity Act Health Equity and Accountability Act S. 2438/H.R. 4665 - FY 24 Department of State, Foreign Operations, and Related Programs Appropriations Act Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars Prevention and Public Health Fund Nicotine Pouches FDA nicotine standard Tobacco Cessation FDA implementation of and enforcement of premarket review Nicotine poisonings from e-cigarettes FDAs strategic plan Congressional Caucus to End the Youth Vaping Epidemic FDA oversight of premium cigars FDA implementation of Tobacco Control Act and hiring authority VA and Tobacco Cancer Moonshot E-cigarette Tax Lung Cancer Screening Labeling Cigarette Filter Waste Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration OMB
Client expense: $193,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2023 · third_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HR 5525 Continuing Appropriations and Border Security Enhancement Act, 2024; HR 2860 Continuing Appropriations Act, 2024 and Other Extensions Act; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2023 · third_quarter · Veterans
Department of Veterans Affairs appropriations and its delivery of benefits and services to veterans, their dependents and survivors: H.Res. 535, H.Res. 612, H.Res. 674, H.Res. 720, H.Res. 740 H.J. Res. 33, HR 1001, HR 1003, HR 104, HR 1078, HR 1083, HR 1089, HR 1097, HR 1139, HR 1144, HR 1166, HR 1169, HR 1179, HR 1182, HR 1188, HR 1191, HR 1226, HR 1266, HR 1277, HR 1278, HR 1282, HR 1311, HR 1315, HR 1329, HR 1378, HR 1402, HR 1529, HR 1530, HR 1554, HR 1606, HR 1609, HR 1616, HR 1639, HR 1655, HR 1659, HR 1669, HR 1708, HR 1753, HR 1767, HR 1774, HR 1786, HR 1799, HR 1815, HR 1822, HR 1948, HR 1950, HR 196, HR 226, HR 228, HR 232, HR 234, HR 236, HR 2398, HR 2410, HR 2413, HR 2414, HR 2431, HR 2441, HR 2469, HR 2472, HR 2499, HR 251, HR 2518, HR 2525, HR 2526, HR 2543, HR 2733, HR 2768, HR 2809, HR 2828, HR 2830, HR 2846, HR 2896, HR 2932, HR 2971, HR 3023, HR 303, HR 3040, HR 3084, HR 3110, HR 3128, HR 3157, HR 3186, HR 3192, HR 3214, HR 3225, HR 3303, HR 3326, HR 333, HR 3363, HR 3368, HR 3450, HR 3489, HR 3499, HR 3504, HR 3511, HR 3581, HR 3584, HR 3600, HR 3601, HR 3644, HR 3648, HR 3649, HR 3651, HR 3676, HR 3677, HR 3698, HR 3718, HR 3720, HR 3722, HR 3751, HR 3790, HR 3811, HR 3848, HR 3870, HR 3895, HR 394, HR 395, HR 4047, HR 41, HR 411, HR 4150, HR 4157, HR 4249, HR 4262, R 4325, HR 4566, HR 4569, HR 4634, HR 4670, HR 4886, HR 4906, HR 491, HR 492, HR 4921, HR 4944, HR 5002, HR 5014, HR 5147, HR 5153, HR 516, HR 5197, HR 522, HR 523, HR 5247, HR 5259, HR 5287, HR 5365, HR 5367, HR 5377, HR 5416, HR 542, HR 5425, HR 543, HR 544, HR 5470, HR 5492, HR 5530, HR 5559, HR 5610, HR 5633, HR 5682, HR 5697, HR 5702, HR 5794, HR 5860, HR 5870, HR 5904, HR 592, HR 602, HR 608, HR 626, HR 645, HR 693, HR 716, HR 728, HR 733, HR 746, HR 754, HR 768, HR 808, HR 815, HR 854, HR 885, HR 894, HR 903, HR 984, S 10, S 1028, S 1037, S 1040, S 106, S 1090, S 1096, S 1100, S 1119, S 1125, S 1172, S 1266, S 1309, S 1314, S 132, S 1330, S 1360, S 141, S 1436, S 1469, S 1515, S 1590, S 1612, S 1635, S 1678, S 1792, S 1828, S 185, S 1951, S 1954, S 1975, S 1994, S 2014, S 2026, S 216, S 2294, S 2315, S 2386, S 24, S 2422, S 2431, S 2465, S 2503, S 2513, S 2516, S 263, S 2679, S 2718, S 2720, S 2745, S 2757, S 2778, S 2795, S 280, S 2801, S 2803, S 2854, S 2863, S 2873, S 291, S 296, S 2975, S 30, S 302, S 326, S 330, S 344, S 350, S 38, S 414, S 42, S 449, S 495, S 498, S 528, S 531, S 547, S 592, S 596, S 609, S 622, S 633, S 656, S 665, S 680, S 725, S 740, S 748, S 774, S 777, S 853, S 897, S 928, S.J. Res. 17, S.Res. 208, S.Res. 264, S.Res. 335, S.Res. 348, S. Res. 365, S. Res. 405
Client expense: $181,319 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS), Veterans Affairs, Dept of (VA), Veterans Employment & Training Service
2023 · first_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Signed onto February 2023 letter of support for the legislation to make VHA facilities smokefree. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor.
Client expense: Not reported · Firm income: Not reported
2023 · second_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. H.R. 3829: Higher Education Marijuana Research Act of 2023. This bill would streamline the process for institutions of higher education to research marijuana. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor.
Client expense: Not reported · Firm income: Not reported
2023 · second_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act; HR 3746 Fiscal Responsibility Act of 2023; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2023 · second_quarter · Veterans
Department of Veterans Affairs appropriations and its delivery of benefits and services to veterans, their dependents and survivors: H.Res. 535, H.J. Res. 33, HR 1001, HR 1003, HR 104, HR 1078, HR 1083, HR 1089, HR 1097, HR 1139, HR 1144, HR 1166, HR 1169, HR 1179, HR 1182, HR 1188, HR 1191, HR 1226, HR 1266, HR 1277, HR 1278, HR 1282, HR 1311, HR 1315, HR 1329, HR 1378, HR 1402, HR 1529, HR 1530, HR 1554, HR 1606, HR 1609, HR 1616, HR 1639, HR 1655, HR 1659, HR 1669, HR 1708, HR 1753, HR 1767, HR 1774, HR 1786, HR 1799, HR 1815, HR 1822, HR 1948, HR 1950, HR 196, HR 226, HR 228, HR 232, HR 234, HR 236, HR 2398, HR 2410, HR 2413, HR 2414, HR 2431, HR 2441, HR 2469, HR 2472, HR 2499, HR 251, HR 2518, HR 2525, HR 2526, HR 2543, HR 2733, HR 2768, HR 2809, HR 2828, HR 2830, HR 2846, HR 2896, HR 2932, HR 2971, HR 3023, HR 303, HR 3040, HR 3084, HR 3110, HR 3128, HR 3157, HR 3186, HR 3192, HR 3214, HR 3225, HR 3303, HR 3326, HR 333, HR 3363, HR 3368, HR 3450, HR 3489, HR 3499, HR 3504, HR 3511, HR 3581, HR 3584, HR 3600, HR 3601, HR 3644, HR 3648, HR 3649, HR 3651, HR 3676, HR 3677, HR 3698, HR 3718, HR 3720, HR 3722, HR 3751, HR 3790, HR 3811, HR 3848, HR 3870, HR 3895, HR 394, HR 395, HR 4047, HR 41, HR 411, HR 4150, HR 4157, HR 4249, HR 4262, HR 4325, HR 4566, HR 491, HR 492, HR 516, HR 522, HR 523, HR 542, HR 543, HR 544, HR 592, HR 602, HR 608, HR 626, HR 645, HR 693, HR 716, HR 728, HR 733, HR 746, HR 754, HR 768, HR 808, HR 815, HR 854, HR 885, HR 894, HR 903, HR 984, S 10, S 1028, S 1037, S 1040, S 106, S 1090, S 1096, S 1100, S 1119, S 1125, S 1172, S 1266, S 1309, S 1314, S 132, S 1330, S 1360, S 141, S 1436, S 1469, S 1515, S 1590, S 1612, S 1635, S 1678, S 1792, S 1828, S 185, S 1951, S 1954, S 1975, S 1994, S 2014, S 2026, S 216, S 2294, S 24, S 263, S 280, S 291, S 296, S 30, S 302, S 326, S 330, S 344, S 350, S 38, S 414, S 42, S 449, S 495, S 498, S 528, S 531, S 547, S 592, S 596, S 609, S 622, S 633, S 656, S 665, S 680, S 725, S 740, S 748, S 774, S 777, S 853, S 897, S 928, S.J. Res. 17, S.Res. 208, S.Res. 264
Client expense: $181,319 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS), Veterans Affairs, Dept of (VA), Veterans Employment & Training Service
2023 · first_quarter · Tobacco
Disposable ENDS Product Enforcement Act (H.R. 901) A bill that would provide for Medicaid and Children's Health Insurance Program coverage of certain tobacco cessation services (no bill number) To amend title 38, United States Code, to prohibit smoking on the premises of the Veterans Health Administration, and for other purposes (H.R. 2398/S. 1040) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product applications FDA nicotine product standards
Client expense: $80,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · first_quarter · Tobacco
Lobbying Report: January 1 - March 31, 2023 (Action Fund) Federal (under tobacco issue code) Legislation: Quit Because of COVID-19 Act FY 24 Senate/House Agriculture, Rural Development, and Food and Drug Administration, and Related Agencies Appropriations Bill FY 24 Senate/House Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill FY 24 Senate/House State, Foreign Operations, and Related Programs Appropriations bill FY 24 Senate/House Commerce, Justice, Science, and Related Agencies Appropriations Bill Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. 901 - Disposable ENDS Product Enforcement Act of 2023 Health Equity and Accountability Act S. 1040 / H.R. 2398 - Smoke-Free VHA Bill S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act Preventing Vape Use Act S. 184 / H.R. 277 - Regulations for Executive in Need of Scrutiny Act Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars FDA regulation of e-cigarettes FDA funding FDA regulation of tobacco, including premarket review and enforcement Tobacco taxes Tobacco product user fees FDA nicotine standard Youth vaping Tobacco cessation CDC Office on Smoking and Health (OSH) funding Tobacco and trade Ending the Youth Vaping Epidemic Caucus Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Tobacco
Lobbying Report: January 1st - March 31st, 2023 (Campaign) Federal (under tobacco issue code) Legislation: Quit Because of COVID-19 Act FY 24 Senate/House Agriculture, Rural Development, and Food and Drug Administration, and Related Agencies Appropriations Bill FY 24 Senate/House Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill FY 24 Senate/House State, Foreign Operations, and Related Programs Appropriations bill FY 24 Senate/House Commerce, Justice, Science, and Related Agencies Appropriations Bill Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. 901 - Disposable ENDS Product Enforcement Act of 2023 Health Equity and Accountability Act S. 1040 / H.R. 2398 - Smoke-Free VHA Bill S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act Preventing Vape Use Act S. 184 / H.R. 277 - Regulations for Executive in Need of Scrutiny Act Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars FDA regulation of e-cigarettes FDA funding FDA regulation of tobacco, including premarket review and enforcement Tobacco taxes Tobacco product user fees FDA nicotine standard Youth vaping Tobacco cessation Office on Smoking and Health (OSH) funding Tobacco and trade Ending the Youth Vaping Epidemic Caucus Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Veterans
Department of Veterans Affairs appropriations and its delivery of benefits and services to veterans, their dependents and survivors: H.J. Res. 33, HR 1001, HR 1003, HR 104, HR 1078, HR 1083, HR 1089, HR 1097, HR 1139, HR 1144, HR 1166, HR 1169, HR 1179, HR 1182, HR 1188, HR 1191, HR 1226, HR 1266, HR 1277, HR 1278, HR 1282, HR 1311, HR 1329, HR 1378, HR 1402, HR 1529, HR 1530, HR 1554, HR 1606, HR 1609, HR 1616, HR 1639, HR 1655, HR 1659, HR 1669, HR 1708, HR 1753, HR 1767, HR 1774, HR 1786, HR 1799, HR 1815, HR 1822, HR 1948, HR 1950, HR 196, HR 226, HR 228, HR 232, HR 234, HR 236, HR 2398, HR 2410, HR 2413, HR 2414, HR 2431, HR 2441, HR 2469, HR 2472, HR 2499, HR 251, HR 2518, HR 2525, HR 2526, HR 303, HR 333, HR 394, HR 395, HR 41, HR 411, HR 491, HR 492, HR 516, HR 522, HR 523, HR 542, HR 543, HR 544, HR 592, HR 602, HR 608, HR 626, HR 645, HR 693, HR 716, HR 728, HR 733, HR 746, HR 754, HR 768, HR 808, HR 815, HR 854, HR 885, HR 894, HR 903, HR 984, S 10, S 1028, S 1037, S 1040, S 106, S 1090, S 1096, S 1100, S 1119, S 1125, S 132, S 141, S 185, S 216, S 24, S 263, S 280, S 296, S 30, S 302, S 326, S 330, S 344, S 38, S 414, S 42, S 449, S 495, S 528, S 531, S 547, S 592, S 596, S 609, S 622, S 633, S 656, S 665, S 680, S 725, S 740, S 748, S 777, S 853, S 897, S 928, S.J. Res. 17
Client expense: $183,150 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS), Veterans Affairs, Dept of (VA), Veterans Employment & Training Service
2023 · first_quarter · Tobacco
H.R.610: Marijuana 1-to-3 Act of 2023. This bill would reschedule marijuana from schedule I to schedule III. Monitor. H.R.901: Disposable ENDS Product Enforcement Act of 2023. This bill would prioritize enforcement of disposable electronic nicotine delivery system products. Monitor. H.R.1486: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. H.R.2398: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S.107: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023. This bill would exempt cigars from FDA regulatory authority. Monitor. S.1040: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor.
Client expense: Not reported · Firm income: Not reported